lymphoma s
DESCRIPTION
Lymphoma s. S. Sami Kartı, MD, Prof. Conceptualizing lymphoma. neoplasms of lymphoid origin, typically causing lymphadenopathy. ALL. CLL. Lymphomas. MM. Neutrophils. AML. Myeloproliferative disorders. Myeloid progenitor. Eosinophils. Hematopoietic stem cell. Basophils. Monocytes. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/1.jpg)
Lymphomas
S. Sami Kartı, MD, Prof.
![Page 2: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/2.jpg)
Conceptualizing lymphoma
neoplasms of lymphoid origin, typically causing lymphadenopathy
![Page 3: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/3.jpg)
ALLALL MM MM CLLCLL LymphomasLymphomas
Hematopoieticstem cell
Neutrophils
Eosinophils
Basophils
Monocytes
Platelets
Red cells
Myeloidprogenitor
Myeloproliferative disordersMyeloproliferative disordersAMLAML
Lymphoidprogenitor T-lymphocytes
Plasmacells
B-lymphocytes
nanaïïveve
![Page 4: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/4.jpg)
B-cell development
stemcell
lymphoidprogenitor
progenitor-B
pre-B
immatureB-cell
memoryB-cell
plasma cellplasma cell
DLBCL,FL, HL
ALL
CLL
MM
germinalgerminalcentercenterB-cellB-cell
maturenaiveB-cell
![Page 5: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/5.jpg)
Clinically useful classification
Diseases that have distinct• clinical features• natural history• prognosis• treatment
Biologically rational classification
Diseases that have distinct• morphology• immunophenotype• genetic features• clinical features
Classification
![Page 6: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/6.jpg)
Lymphoma classification (2001 WHO)
B-cell neoplasms precursor mature
T-cell & NK-cell neoplasms precursor mature
Hodgkin lymphoma
Non-HodgkinLymphomas
![Page 7: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/7.jpg)
A practical way to think of lymphoma
Category Survival of untreated patients
Curability To treat or not to treat
Non-Hodgkin lymphoma
Indolent Years Generally not curable
Generally defer Rx if asymptomatic
Aggressive Months Curable in some
Treat
Very aggressive
Weeks Curable in some
Treat
Hodgkin lymphoma
All types Variable – months to years
Curable in most
Treat
![Page 8: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/8.jpg)
Mechanisms of lymphomagenesis
Genetic alterations Infection Antigen stimulation Immunosuppression
![Page 9: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/9.jpg)
Epidemiology of lymphomas
5th most frequently diagnosed cancer in both sexes
males > females incidence
NHL increasing Hodgkin lymphoma stable
![Page 10: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/10.jpg)
Risk factors for NHL
immunosuppression or immunodeficiency
connective tissue disease family history of lymphoma infectious agents ionizing radiation
![Page 11: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/11.jpg)
Clinical manifestations Variable
severity: asymptomatic to extremely ill time course: evolution over weeks, months, or
years
Systemic manifestations fever, night sweats, weight loss, anorexia, pruritis
Local manifestations lymphadenopathy, splenomegaly most common any tissue potentially can be infiltrated
![Page 12: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/12.jpg)
Other complications of lymphoma
bone marrow failure (infiltration) CNS infiltration immune hemolysis or
thrombocytopenia compression of structures (eg spinal
cord, ureters) pleural/pericardial effusions, ascites
![Page 13: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/13.jpg)
Diagnosis requires an adequate biopsy
Diagnosis should be biopsy-proven before treatment is initiated
Need enough tissue to assess cells and architecture open bx vs core needle bx vs FNA
![Page 14: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/14.jpg)
Stage I Stage II Stage III Stage IV
Staging of lymphoma
A: absence of B symptomsB: fever, night sweats, weight loss
![Page 15: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/15.jpg)
Three common lymphomas
Diffuse large B-cell lymphoma Follicular lymphoma Hodgkin lymphoma
![Page 16: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/16.jpg)
Relative frequencies of different lymphomas
Hodgkinlymphoma
NHL
Diffuse large B-cell
Follicular
Other NHL
Non-Hodgkin Lymphomas
~85% of NHL are B-lineage
![Page 17: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/17.jpg)
Follicular lymphoma most common type of “indolent”
lymphoma usually widespread at presentation often asymptomatic not curable (some exceptions) associated with BCL-2 gene
rearrangement [t(14;18)] cell of origin: germinal center B-cell
![Page 18: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/18.jpg)
defer treatment if asymptomatic (“watch-and-wait”)
several chemotherapy options if symptomatic
median survival: years despite “indolent” label, morbidity
and mortality can be considerable transformation to aggressive
lymphoma can occur
![Page 19: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/19.jpg)
Diffuse large B-cell lymphoma
![Page 20: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/20.jpg)
Introduction
most common type of “aggressive” lymphoma
extranodal involvement is common cell of origin: germinal center B-cell
![Page 21: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/21.jpg)
Clinical presentation
Usually presents with one or more rapidly growing tumor masses involving nodal or extranodal sites
Not tender Usually not interfere organ function
except by compression
![Page 22: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/22.jpg)
Treatment
Chemotherapy Radiotherapy Chemotherapy + radiotherapy Autologous or allogeneic stem cell
transplantation in relaps or refractory cases
![Page 23: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/23.jpg)
Hodgkin lymphoma
Thomas Hodgkin(1798-1866)
![Page 24: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/24.jpg)
Classical Hodgkin Lymphoma
![Page 25: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/25.jpg)
Hodgkin lymphoma
cell of origin: germinal centre B-cell Reed-Sternberg cells (or RS variants)
in the affected tissues most cells in affected lymph node are
polyclonal reactive lymphoid cells, not neoplastic cells
![Page 26: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/26.jpg)
Reed-Sternberg cell
![Page 27: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/27.jpg)
RS cell and variants
popcorn celllacunar cellclassic RS cell
![Page 28: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/28.jpg)
A possible model of pathogenesis
germinalcentreB cell
transformingevent(s)
loss of apoptosis
RS cellinflammatory
response
EBV?
cytokines
![Page 29: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/29.jpg)
Histologic subtypes
Classical Hodgkin lymphoma nodular sclerosis (most common subtype) mixed cellularity lymphocyte-rich lymphocyte depleted
![Page 30: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/30.jpg)
Epidemiology
less frequent than non-Hodgkin lymphoma
overall M>F peak incidence in 3rd decade
![Page 31: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/31.jpg)
Associated (etiological?) factors
EBV infection smaller family size higher socio-economic status caucasian > non-caucasian possible genetic predisposition other: HIV? occupation? herbicides?
![Page 32: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/32.jpg)
Clinical manifestations
lymphadenopathy extranodal sites relatively uncommon
except in advanced disease “B” symptoms
![Page 33: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/33.jpg)
Treatment and Prognosis
Stage Treatment Overall 5 year
survival
I,II ABVD x 2-4 & radiation
80-90%
III,IV ABVD x 6-8 70-80%
![Page 34: Lymphoma s](https://reader036.vdocuments.us/reader036/viewer/2022081603/56814f2c550346895dbcb805/html5/thumbnails/34.jpg)
Long term complications of treatment
infertility MOPP > ABVD; males > females sperm banking should be discussed premature menopause
secondary malignancy skin, AML, lung, MDS, NHL, thyroid,
breast... cardiac disease